Four notes:
1. Robotic pull-through, product launches, a resurgence in the biologic business, and competitive recruiting contributed to growth in the first quarter, the company said in a May 4 news release.
2. First-quarter net income was $45.3 million, a 74.7 percent year-over-increase from $25.9 million in the first quarter of 2020.
3. CEO Dave Demski said “enabling technologies revenue increased 86 percent, as surgeon recognition of the clinical superiority of our robotic technology produced back-to-back quarters of strong year-over-year growth.”
4. As of March 31, cash, cash equivalents and marketable securities were $838.4 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
